Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Springfield, IL
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Springfield, IL
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Jeffersonville, IN
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Jeffersonville, IN
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
West Des Moines, IA
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
West Des Moines, IA
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Shreveport, LA
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Shreveport, LA
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Royal Oak, MI
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Albuquerque, NM
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Lake Success, NY
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Lake Success, NY
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Charlotte, NC
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Raleigh, NC
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Wilmington, NC
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Wilmington, NC
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Cleveland, OH
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Oklahoma City, OK
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Philadelphia, PA
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Dallas, TX
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
Research Site
mi
from
Brampton,
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Research Site
mi
from
Brampton,
Click here to add this to my saved trials
Risperidone Plus Mood Stabilizer in Treatment of Mixed Mania
Risperidone Plus Mood Stabilizer in the Treatment of Mixed Mania
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center
mi
from
San Antonio, TX
Risperidone Plus Mood Stabilizer in Treatment of Mixed Mania
Risperidone Plus Mood Stabilizer in the Treatment of Mixed Mania
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Outpatient Adolescent Treatment for Comorbid Substance Use and Internalizing Disorders
Development of Outpatient MST for Dually Diagnosed Youth
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina, Department of Psychiatry & Behavioral Sciences, Family Services Research Center
mi
from
Charleston, SC
Outpatient Adolescent Treatment for Comorbid Substance Use and Internalizing Disorders
Development of Outpatient MST for Dually Diagnosed Youth
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina, Department of Psychiatry & Behavioral Sciences, Family Services Research Center
mi
from
Charleston, SC
Click here to add this to my saved trials
Evaluating the Methylphenidate Patch to Treat Former Stimulant Users With ADHD
The Evaluation of the Safety and Efficacy of the Methylphenidate Patch in Former Stimulant Users With ADHD
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Evaluating the Methylphenidate Patch to Treat Former Stimulant Users With ADHD
The Evaluation of the Safety and Efficacy of the Methylphenidate Patch in Former Stimulant Users With ADHD
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
The Effects of Theta Burst Stimulation on the Brain Response to Drug and Alcohol Cues
The Effects of a Single Session of Real Versus Sham Theta Burst Stimulation on the Brain Response to Drug-cues
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
The Effects of Theta Burst Stimulation on the Brain Response to Drug and Alcohol Cues
The Effects of a Single Session of Real Versus Sham Theta Burst Stimulation on the Brain Response to Drug-cues
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Epidemiology of Sleep-Disordered Breathing in Adults
Epidemiology of Sleep-Disordered Breathing in Adults
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Epidemiology of Sleep-Disordered Breathing in Adults
Epidemiology of Sleep-Disordered Breathing in Adults
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Memantine and Naltrexone Treatment for Opioid Dependence
Evaluation of NMDA Antagonist for Opiate Dependence
Status: Enrolling
Updated:  12/31/1969
New York State Psychiatric Institute
mi
from
New York, NY
Memantine and Naltrexone Treatment for Opioid Dependence
Evaluation of NMDA Antagonist for Opiate Dependence
Status: Enrolling
Updated: 12/31/1969
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
Study of Quetiapine Treatment for Cannabis Dependence
Open-Label Pilot Study of Quetiapine Treatment for Cannabis Dependence
Status: Enrolling
Updated:  12/31/1969
Substance Treatment and Research Service (STARS), Columbia University
mi
from
New York, NY
Study of Quetiapine Treatment for Cannabis Dependence
Open-Label Pilot Study of Quetiapine Treatment for Cannabis Dependence
Status: Enrolling
Updated: 12/31/1969
Substance Treatment and Research Service (STARS), Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Clinical Decision Support for Opioid Use Disorders in Medical Settings: Usability Testing in an EMR
Clinical Decision Support for Opioid Use Disorders in Medical Settings: Pilot Usability Testing in an EMR
Status: Enrolling
Updated:  12/31/1969
HealthPartners
mi
from
Bloomington, MN
Clinical Decision Support for Opioid Use Disorders in Medical Settings: Usability Testing in an EMR
Clinical Decision Support for Opioid Use Disorders in Medical Settings: Pilot Usability Testing in an EMR
Status: Enrolling
Updated: 12/31/1969
HealthPartners
mi
from
Bloomington, MN
Click here to add this to my saved trials
Implementation and Evaluation of SBIRT
Phased Multisite Cluster Randomized Trial Testing Screening, Brief Intervention, Referral to Treatment for People That Use Tobacco, Alcohol, and Non-prescription Drugs
Status: Enrolling
Updated:  12/31/1969
Indiana University
mi
from
Indianapolis, IN
Implementation and Evaluation of SBIRT
Phased Multisite Cluster Randomized Trial Testing Screening, Brief Intervention, Referral to Treatment for People That Use Tobacco, Alcohol, and Non-prescription Drugs
Status: Enrolling
Updated: 12/31/1969
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
START & STOPP in GWI
START & STOPP in GWI
Status: Enrolling
Updated:  12/31/1969
Georgetown University
mi
from
Washington,
START & STOPP in GWI
START & STOPP in GWI
Status: Enrolling
Updated: 12/31/1969
Georgetown University
mi
from
Washington,
Click here to add this to my saved trials
Emotional Working Memory Training for Veterans With PTSD Symptoms
Emotional Working Memory Training for Veterans With Elevated Trauma-related Symptoms
Status: Enrolling
Updated:  12/31/1969
Clement J. Zablocki VA Medical Center
mi
from
Milwaukee, WI
Emotional Working Memory Training for Veterans With PTSD Symptoms
Emotional Working Memory Training for Veterans With Elevated Trauma-related Symptoms
Status: Enrolling
Updated: 12/31/1969
Clement J. Zablocki VA Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Levetiracetam for the Treatment of Alcohol Dependence and Anxiety
Pilot Trial of Levetiracetam in the Treatment of Alcohol Dependence With Comorbid Anxiety
Status: Enrolling
Updated:  12/31/1969
New York State Psychiatric Institute
mi
from
New York, NY
Levetiracetam for the Treatment of Alcohol Dependence and Anxiety
Pilot Trial of Levetiracetam in the Treatment of Alcohol Dependence With Comorbid Anxiety
Status: Enrolling
Updated: 12/31/1969
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
Cognitive and Psychophysiological Effects of Delta-9-Tetrahydrocannabinol in Bipolar Disorder
Cognitive and Psychophysiological Effects of Delta-9-Tetrahydrocannabinol in Bipolar Disorder
Status: Enrolling
Updated:  12/31/1969
Biological Studies Unit, VA Connecticut Healthcare System
mi
from
West Haven, CT
Cognitive and Psychophysiological Effects of Delta-9-Tetrahydrocannabinol in Bipolar Disorder
Cognitive and Psychophysiological Effects of Delta-9-Tetrahydrocannabinol in Bipolar Disorder
Status: Enrolling
Updated: 12/31/1969
Biological Studies Unit, VA Connecticut Healthcare System
mi
from
West Haven, CT
Click here to add this to my saved trials
Enhancement of Therapeutic Learning in OCD Using tDCS
Enhancement of Therapeutic Learning in Obsessive-compulsive Disorder Using Transcranial Direct Current Stimulation
Status: Enrolling
Updated:  12/31/1969
Connecticut Mental Health Center
mi
from
New Haven, CT
Enhancement of Therapeutic Learning in OCD Using tDCS
Enhancement of Therapeutic Learning in Obsessive-compulsive Disorder Using Transcranial Direct Current Stimulation
Status: Enrolling
Updated: 12/31/1969
Connecticut Mental Health Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Development and Pilot Testing of the Students With Autism Accessing General Education (SAAGE) Model
Development and Pilot Testing of the Students With Autism Accessing General Education (SAAGE) Model
Status: Enrolling
Updated:  12/31/1969
Univ of Rochester Medical Center
mi
from
Rochester, NY
Development and Pilot Testing of the Students With Autism Accessing General Education (SAAGE) Model
Development and Pilot Testing of the Students With Autism Accessing General Education (SAAGE) Model
Status: Enrolling
Updated: 12/31/1969
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
D-Cycloserine and Cue Exposure in Cocaine-Dependent Individuals
D-Cycloserine and Cue Exposure in Cocaine-Dependent Individuals
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
D-Cycloserine and Cue Exposure in Cocaine-Dependent Individuals
D-Cycloserine and Cue Exposure in Cocaine-Dependent Individuals
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Brief Motivational Intervention to Improve Medication Adherence for Adolescents With Bipolar Disorder
Brief Motivational Intervention to Improve Medication Adherence for Adolescents With Bipolar Disorder
Status: Enrolling
Updated:  12/31/1969
Western Psychiatric Institute and Clinic, University of Pittsburgh
mi
from
Pittsburgh, PA
Brief Motivational Intervention to Improve Medication Adherence for Adolescents With Bipolar Disorder
Brief Motivational Intervention to Improve Medication Adherence for Adolescents With Bipolar Disorder
Status: Enrolling
Updated: 12/31/1969
Western Psychiatric Institute and Clinic, University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Feasibility of Providing Computerized CBT in the Black Church
A Pilot Feasibility Study of Providing Substance Use Treatment in the Black Church
Status: Enrolling
Updated:  12/31/1969
Dixwell Ave Congregational United Church of Christ
mi
from
New Haven, CT
Feasibility of Providing Computerized CBT in the Black Church
A Pilot Feasibility Study of Providing Substance Use Treatment in the Black Church
Status: Enrolling
Updated: 12/31/1969
Dixwell Ave Congregational United Church of Christ
mi
from
New Haven, CT
Click here to add this to my saved trials
HIV, Buprenorphine, and the Criminal Justice System (STRIDE2)
Project STRIDE2 - Seek/Test/Retain: PLWHA and Opioid Users in Washington, DC
Status: Enrolling
Updated:  12/31/1969
Howard University
mi
from
Washington,
HIV, Buprenorphine, and the Criminal Justice System (STRIDE2)
Project STRIDE2 - Seek/Test/Retain: PLWHA and Opioid Users in Washington, DC
Status: Enrolling
Updated: 12/31/1969
Howard University
mi
from
Washington,
Click here to add this to my saved trials
Early Assessment and Intervention for Adolescents at Risk for Bipolar Disorder
Early Assessment and Intervention for Adolescents at Risk for Bipolar Disorder
Status: Enrolling
Updated:  12/31/1969
Western Psychiatric Institute and Clinic, University of Pittsburgh
mi
from
Pittsburgh, PA
Early Assessment and Intervention for Adolescents at Risk for Bipolar Disorder
Early Assessment and Intervention for Adolescents at Risk for Bipolar Disorder
Status: Enrolling
Updated: 12/31/1969
Western Psychiatric Institute and Clinic, University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
The Impact of Teacher Nonverbal Behaviors on Children's Intergroup Attitudes and Mental Health
The Impact of Teacher Nonverbal Behaviors on Children's Intergroup Attitudes and Mental Health
Status: Enrolling
Updated:  12/31/1969
University of Hawaii at Manoa
mi
from
Honolulu, HI
The Impact of Teacher Nonverbal Behaviors on Children's Intergroup Attitudes and Mental Health
The Impact of Teacher Nonverbal Behaviors on Children's Intergroup Attitudes and Mental Health
Status: Enrolling
Updated: 12/31/1969
University of Hawaii at Manoa
mi
from
Honolulu, HI
Click here to add this to my saved trials
Improving the Medication Management of Patients With Attention-Deficit Hyperactivity Disorder
Improving the Medication Management of Patients With Attention-Deficit Hyperactivity Disorder
Status: Enrolling
Updated:  12/31/1969
American Academy of Pediatrics
mi
from
Elk Grove Village, IL
Improving the Medication Management of Patients With Attention-Deficit Hyperactivity Disorder
Improving the Medication Management of Patients With Attention-Deficit Hyperactivity Disorder
Status: Enrolling
Updated: 12/31/1969
American Academy of Pediatrics
mi
from
Elk Grove Village, IL
Click here to add this to my saved trials
Treatment of Asian Flushing Syndrome With Topical Alpha Agonists
Treatment of Asian Flushing Syndrome With Topical Alpha Agonists
Status: Enrolling
Updated:  12/31/1969
UC San Francisco
mi
from
San Francisco, CA
Treatment of Asian Flushing Syndrome With Topical Alpha Agonists
Treatment of Asian Flushing Syndrome With Topical Alpha Agonists
Status: Enrolling
Updated: 12/31/1969
UC San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
The Effect of a Contingency Management Intervention on Substance Use
Effectiveness of Contingency Management in VA Addictions Treatment
Status: Enrolling
Updated:  12/31/1969
Minneapolis VA Health Care System, Minneapolis, MN
mi
from
Minneapolis, MN
The Effect of a Contingency Management Intervention on Substance Use
Effectiveness of Contingency Management in VA Addictions Treatment
Status: Enrolling
Updated: 12/31/1969
Minneapolis VA Health Care System, Minneapolis, MN
mi
from
Minneapolis, MN
Click here to add this to my saved trials
The Effect of a Contingency Management Intervention on Substance Use
Effectiveness of Contingency Management in VA Addictions Treatment
Status: Enrolling
Updated:  12/31/1969
VA Puget Sound Health Care System Seattle Division, Seattle, WA
mi
from
Seattle, WA
The Effect of a Contingency Management Intervention on Substance Use
Effectiveness of Contingency Management in VA Addictions Treatment
Status: Enrolling
Updated: 12/31/1969
VA Puget Sound Health Care System Seattle Division, Seattle, WA
mi
from
Seattle, WA
Click here to add this to my saved trials
Rapamycin as a Means of Interference With Reconsolidation of Posttraumatic Stress Disorder-related Traumatic Memory
mTOR Kinase as a Therapeutic Target in Reconsolidation of Posttraumatic Stress Disorder-related Traumatic Memory
Status: Enrolling
Updated:  12/31/1969
VA North Texas Healthcare System
mi
from
Dallas, TX
Rapamycin as a Means of Interference With Reconsolidation of Posttraumatic Stress Disorder-related Traumatic Memory
mTOR Kinase as a Therapeutic Target in Reconsolidation of Posttraumatic Stress Disorder-related Traumatic Memory
Status: Enrolling
Updated: 12/31/1969
VA North Texas Healthcare System
mi
from
Dallas, TX
Click here to add this to my saved trials
Preventing Drug Abuse Among Hispanic Adolescents
Drug Abuse Prevention Programming for Hispanic Adolescents
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Preventing Drug Abuse Among Hispanic Adolescents
Drug Abuse Prevention Programming for Hispanic Adolescents
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Adapting Alcohol Behavioral Couple Therapy for Service Members in Post-Deployment
Adapting Alcohol Behavioral Couple Therapy for Service Members in Post-Deployment
Status: Enrolling
Updated:  12/31/1969
Univ of Massachusetts Med School
mi
from
Worcester, MA
Adapting Alcohol Behavioral Couple Therapy for Service Members in Post-Deployment
Adapting Alcohol Behavioral Couple Therapy for Service Members in Post-Deployment
Status: Enrolling
Updated: 12/31/1969
Univ of Massachusetts Med School
mi
from
Worcester, MA
Click here to add this to my saved trials
Targeting Sleep in Kids With Autism Spectrum Disorder
Targeting Sleep in Kids With Autism Spectrum Disorder
Status: Enrolling
Updated:  12/31/1969
Department of Health Psychology, University of Missouri-Columbia
mi
from
Columbia, MO
Targeting Sleep in Kids With Autism Spectrum Disorder
Targeting Sleep in Kids With Autism Spectrum Disorder
Status: Enrolling
Updated: 12/31/1969
Department of Health Psychology, University of Missouri-Columbia
mi
from
Columbia, MO
Click here to add this to my saved trials
CAMS-RAS: for Suicide Prevention
CAMS Relational Agent System for Suicide Prevention
Status: Enrolling
Updated:  12/31/1969
Evidence-Based Practice Institute
mi
from
Seattle, WA
CAMS-RAS: for Suicide Prevention
CAMS Relational Agent System for Suicide Prevention
Status: Enrolling
Updated: 12/31/1969
Evidence-Based Practice Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
An Initial Feasibility Study of Brief Cognitive Behavioral Therapy for Suicidal Inpatients
An Initial Feasibility Study of Brief Cognitive Behavioral Therapy for Suicidal Inpatients
Status: Enrolling
Updated:  12/31/1969
Institute of Living
mi
from
Hartford, CT
An Initial Feasibility Study of Brief Cognitive Behavioral Therapy for Suicidal Inpatients
An Initial Feasibility Study of Brief Cognitive Behavioral Therapy for Suicidal Inpatients
Status: Enrolling
Updated: 12/31/1969
Institute of Living
mi
from
Hartford, CT
Click here to add this to my saved trials
PART B: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and Without mGluR Mutations
A Multicenter, 2-Part, 6-Week, Double-blind, Randomized, Placebo-controlled, Parallel-design Study to Assess the Efficacy and Safety of AEVI-001 in Children and Adolescents (Ages 6-17 Years) With Attention Deficit Hyperactivity Disorder and With or Without Copy Number Variants in Specific Genes Implicated in Glutamatergic Signaling and Neuronal Connectivity
Status: Enrolling
Updated:  12/31/1969
Aevi Genomic Medicine
mi
from
Wayne, PA
PART B: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and Without mGluR Mutations
A Multicenter, 2-Part, 6-Week, Double-blind, Randomized, Placebo-controlled, Parallel-design Study to Assess the Efficacy and Safety of AEVI-001 in Children and Adolescents (Ages 6-17 Years) With Attention Deficit Hyperactivity Disorder and With or Without Copy Number Variants in Specific Genes Implicated in Glutamatergic Signaling and Neuronal Connectivity
Status: Enrolling
Updated: 12/31/1969
Aevi Genomic Medicine
mi
from
Wayne, PA
Click here to add this to my saved trials
Pharmacokinetic Study of DYANAVEL XR (Amphetamine) Extended-release Oral Suspension, in Children Aged 4 to 5 Years
Pharmacokinetic Study of DYANAVEL XR (Amphetamine) Extended-release Oral Suspension, in Children Aged 4 to 5 Years With Attention-deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  12/31/1969
Meridien Research, Inc.
mi
from
Maitland, FL
Pharmacokinetic Study of DYANAVEL XR (Amphetamine) Extended-release Oral Suspension, in Children Aged 4 to 5 Years
Pharmacokinetic Study of DYANAVEL XR (Amphetamine) Extended-release Oral Suspension, in Children Aged 4 to 5 Years With Attention-deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 12/31/1969
Meridien Research, Inc.
mi
from
Maitland, FL
Click here to add this to my saved trials
Oxytocin and Stress Response in Alcohol Use Disorder
Impact of Oxytocin on Neurobiologic Substrates of Social Stress in Individuals With Alcohol Use Disorder
Status: Enrolling
Updated:  12/31/1969
Addiction Sciences Division-Medical University of South Carolina
mi
from
Charleston, SC
Oxytocin and Stress Response in Alcohol Use Disorder
Impact of Oxytocin on Neurobiologic Substrates of Social Stress in Individuals With Alcohol Use Disorder
Status: Enrolling
Updated: 12/31/1969
Addiction Sciences Division-Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Quality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or Acquaintance
Quality of Life in Younger Breast Cancer Survivors
Status: Enrolling
Updated:  12/31/1969
Community Hospital of the Monterey Peninsula Comprehensive Cancer Center
mi
from
Monterey, CA
Quality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or Acquaintance
Quality of Life in Younger Breast Cancer Survivors
Status: Enrolling
Updated: 12/31/1969
Community Hospital of the Monterey Peninsula Comprehensive Cancer Center
mi
from
Monterey, CA
Click here to add this to my saved trials